Sahir Sultan Alvi

6PUBLICATIONS
26CO-AUTHORS
Molecular targetsMetabolic medicinePredictive and prognostic markersBiologically active moleculesGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 07, 2025
Ubiquitination of Oncogenic Mutant p53 via Attenuation of Ribosome Biogenesis Machinery Effectively Inhibits Pancreatic Tumor Growth.

Mudassier Ahmad, Sahir Sultan Alvi, Haider Ahsan

|Oct 16, 2024
Honey Targets Ribosome Biogenesis Components to Suppress the Growth of Human Pancreatic Cancer Cells.

Aun Ali Bangash, Sahir Sultan Alvi, Muhammad Ali Bangash

|Sep 03, 2024
Organosulfur Compounds, S-Allyl-L-Cysteine and S-Ethyl-L-Cysteine, Target PCSK-9/LDL-R-Axis to Ameliorate Cardiovascular, Hepatic, and Metabolic Changes in High Carbohydrate and High Fat Diet-Induced Metabolic Syndrome in Rats.

Parvej Ahmad, Arunim Shah, Mohd Waiz

|Jul 17, 2023
Association of circulatory PCSK-9 with biomarkers of redox imbalance and inflammatory cascades in the prognosis of diabetes and associated complications: a pilot study in the Indian population.

Mohd Waiz, Sahir Sultan Alvi, M Salman Khan

|Apr 28, 2023
Novel Functionalized Spiro [Indoline-3,5'-pyrroline]-2,2'dione Derivatives: Synthesis, Characterization, Drug-Likeness, ADME, and Anticancer Potential.

Mohd Asif, Sahir Sultan Alvi, Tazeen Azaz

|Oct 29, 2021
Glycyrrhizic Acid Scavenges Reactive Carbonyl Species and Attenuates Glycation-Induced Multiple Protein Modification: An In Vitro and In Silico Study.

Sahir Sultan Alvi, Rabia Nabi, Mohd Shahnawaz Khan

Pageof 1

Frequent Collaborators

2 joint publications

M Salman Khan

2 joint publications

Haider Ahsan

2 joint publications

Dae Joon Kim

1 joint publications

Mohd Shahnawaz Khan